These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19256044)

  • 1. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment.
    Grella CE
    J Psychoactive Drugs; 2008 Nov; Suppl 5():327-43. PubMed ID: 19256044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health context of women's mental health research.
    Blehar MC
    Psychiatr Clin North Am; 2003 Sep; 26(3):781-99. PubMed ID: 14563109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women and addiction: the importance of gender issues in substance abuse research.
    Tuchman E
    J Addict Dis; 2010 Apr; 29(2):127-38. PubMed ID: 20407972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance abuse among native Hawaiian women in the United States: a review of current literature and recommendations for future research.
    Ta VM; Chen T
    J Psychoactive Drugs; 2008 Nov; Suppl 5():411-22. PubMed ID: 19248398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of substance abuse treatment programming for women: a review.
    Ashley OS; Marsden ME; Brady TM
    Am J Drug Alcohol Abuse; 2003; 29(1):19-53. PubMed ID: 12731680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of women-only and mixed-gender drug abuse treatment programs.
    Grella CE; Polinsky ML; Hser YI; Perry SM
    J Subst Abuse Treat; 1999; 17(1-2):37-44. PubMed ID: 10435251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of substance abuse during pregnancy.
    Lester BM; Twomey JE
    Womens Health (Lond); 2008 Jan; 4():67-77. PubMed ID: 19072452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the impact of comprehensive services in substance abuse treatment.
    Marsh JC; Cao D; D'Aunno T
    J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Substance Abuse Treatment: Gender Differences among Participants in an Aftercare Program.
    Yeom HS
    Soc Work Public Health; 2015; 30(7):578-91. PubMed ID: 26457926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse treatment for women: changes in the settings where women received treatment and types of services provided, 1987-1998.
    Grella CE; Greenwell L
    J Behav Health Serv Res; 2004; 31(4):367-83. PubMed ID: 15602139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences by Gender in Predictors of Motivation Among Substance Abuse Treatment Participants.
    Taylor LR; Caudy M; Blasko BL; Taxman FS
    Subst Use Misuse; 2017 Mar; 52(4):468-476. PubMed ID: 28001464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized substance abuse treatment for women and their children: an analysis of program design.
    Uziel-Miller ND; Lyons JS
    J Subst Abuse Treat; 2000 Dec; 19(4):355-67. PubMed ID: 11166500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers?
    Heslin KC; Gable A; Dobalian A
    Womens Health Issues; 2015; 25(6):666-72. PubMed ID: 26329259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in Afghan drug-abuse treatment: an assessment of treatment entry characteristics, dropout, and outcomes.
    Abadi MH; Shamblen SR; Courser M; Johnson KW; Thompson K; Young L; Browne T
    Ethn Health; 2015; 20(5):453-73. PubMed ID: 24920072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity in relapse prevention needs: gender and race comparisons among substance abuse treatment patients.
    Walton MA; Blow FC; Booth BM
    Am J Drug Alcohol Abuse; 2001 May; 27(2):225-40. PubMed ID: 11417937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse issues among women in domestic violence programs: findings from North Carolina.
    Martin SL; Moracco KE; Chang JC; Council CL; Dulli LS
    Violence Against Women; 2008 Sep; 14(9):985-97. PubMed ID: 18703771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policies and services in residential substance abuse programs: comparisons with psychiatric programs.
    Timko C
    J Subst Abuse; 1995; 7(1):43-59. PubMed ID: 7655311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.